top of page

Byeong Yoon, PhD: A New Treatment Option for ES-SCLC

Learn about a new treatment option for SCLC from Byeong Yoon, PhD is Vice President, Head of Amgen’s US Oncology Medical Affairs in this Expert Speaker Video.


This video was recorded during the LiveLung Small Cell Lung Cancer meeting on June 18, 2024.





Subscribe to our YouTube channel and click the notification bell so you know when new educational lung cancer videos are available https://www.youtube.com/livelung


About the Speaker Byeong Yoon, PhD is Vice President, Head of Amgen’s US Oncology Medical Affairs team. In his role, Byeong oversees his team to lead the US medical affairs strategy and activities for Amgen’s oncology portfolio. He has held multiple leadership positions within Global and US Medical affairs over the past 15 years, and has been in the pharmaceutical industry for almost 20 years. During that time, he’s had the privilege of working on a number of therapies in oncology, inflammatory, and cardiovascular diseases, including helping bring new therapies to patients suffering from these diseases.


The LiveLung Small Cell Lung Cancer Program is supported in-part by grants from AstraZeneca, Amgen, and Jazz Pharmaceutical.


This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.


LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.

bottom of page